AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Manufacturers of some diabetes drugs to strengthen warning on heart failure risk.(Industry News)

Pharmaceutical Processing

| September 01, 2007 | COPYRIGHT 2009 Advantage Business Media. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

The FDA recently announced that manufacturers of certain drugs approved to treat Type 2 diabetes have agreed to add a stronger warning on the risk of heart failure, a condition that occurs when the heart does not adequately pump blood. The information will be included in the form of a "boxed" warning--FDA's strongest form of a warning. The upgraded warning emphasizes that the drugs may cause or worsen heart failure in certain patients.

After a review of postmarketing adverse event reports, FDA determined that an updated label with a boxed warning on the risks of heart failure was needed for the entire thiazolidinedione class of antidiabetic drugs. This class includes…

Related articles from newspapers, magazines, journals, and more
InSync ICD for heart failure gets FDA nod. (Product Pipeline).(Medtronic Inc.)
Newspaper article from: Cardiovascular Device Update August 1, 2002 700+ words
...which last month received FDA approval for its InSync...defibrillator) system for heart failure received FDA approval, a little over...only company with two FDA-approved cardiac resynchronization...specific segments of heart failure patients--those who...
Blood Test for Heart Failure Gets FDA Approval.(Brief Article)
Magazine article from: Family Practice News ZOLER, MITCHEL L. January 1, 2001 700+ words
...identifying patients with heart failure. In recently reported...specific for diagnosing heart failure in 250 emergency department...approving the test, the FDA reviewed results from...The experts diagnosed heart failure in 97 patients. The...
GlaxoSmithKline (London) reported FDA approval of Coreg (carvedilol) for the...
Newspaper article from: The BBI Newsletter December 1, 2001 700+ words
...London) reported FDA approval of Coreg...treatment of severe heart failure. Coreg is already...moderate and severe heart failure patients, the company...the progression of heart failure. The FDA approval is based on...
Aldagen and Texas Heart Institute to Begin Clinical Study of Stem Cell Therapy...
Press release article from: Business Wire February 21, 2006 700+ words
...Drug Administration (FDA) has cleared a clinical...therapy for advanced heart failure patients. It will be...population for therapy for heart failure patients in the United...very excited about the FDA clearance to begin this...
Two hundred patients receive heart failure device, FDA approves new trial.
Newspaper article from: Cardiovascular Week September 8, 2003 700+ words
...designed for end-stage heart failure patients who can no longer...devastating congestive heart failure after a severe acute...milestone-approval from the FDA to begin its Destination...submitted an application to FDA for approval of the pediatric...
Aldagen and Texas Heart Institute to begin clinical study of stem cell therapy...
News wire article from: Chemical Business Newsbase February 21, 2006 700+ words
...the US Food and Drug Administration (FDA) has cleared a clinical study for physicians...cell population for therapy for advanced heart failure patients. It will be the first clinical...unique cell population for therapy for heart failure patients in the US. Aldesort isolates...
PRESS RELEASE: Coreg (carvedilol) receives FDA approval for treatment of severe...
News wire article from: Chemical Business Newsbase November 7, 2001 700+ words
...Drug Administration (FDA) approved Coreg...treatment of severe heart failure. Coreg is already...moderate, and severe heart failure patients. The FDA granted marketing...for Coreg in severe heart failure based on a review...
NEW CONGESTIVE HEART FAILURE DRUG RECEIVES FDA APPROVAL
Press release article from: PR Newswire December 31, 1992 700+ words
...Represents First New Class of Heart Failure Drugs in a Decade LINCOLNSHIRE...Drug Administration (FDA) to market MANOPLAX...treatment of congestive heart failure (CHF). Developed...treatment of congestive heart failure. An IP3 (inositol...
FDA Advisory Committee Issues Split Decision on Recommendation To Approve...
Press release article from: PR Newswire October 11, 2001 700+ words
...for the treatment of heart failure. Advisory Committees to the FDA provide independent opinions...decisions are made by the FDA. The supplemental new...sNDA) for Diovan for heart failure was filed with the FDA on April 27, 2001, and...
FDA Accepts New Drug Application for Bucindolol, A Genetically-Targeted...
Press release article from: PR Newswire September 23, 2008 700+ words
...Food and Drug Administration (FDA) has accepted a New Drug Application...for the treatment of chronic heart failure. If approved by the FDA, bucindolol could become the...hospitalizations and deaths in heart failure patients with a specific...
For more facts and information, see all results

Source: HighBeam Research, Manufacturers of some diabetes drugs to strengthen warning on heart...

©2010 Gale, a part of Cengage Learning. All rights reserved. About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily